We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$374M
AUM Growth
-$43.6M
(-10%)
Cap. Flow
-$66M
Cap. Flow
% of AUM
-17.63%
Top 10 Holdings %
Top 10 Hldgs %
5.06%
Holding
1,045
New
320
Increased
158
Reduced
228
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MacroGenics
MGNX
|
+$1.88M |
| 2 |
OSG
Overseas Shipholding Group Inc.
OSG
|
+$1.69M |
| 3 |
CHMT
Chemtura Corporation
CHMT
|
+$1.67M |
| 4 |
INST
Instructure, Inc.
INST
|
+$1.65M |
| 5 |
RP
RealPage, Inc.
RP
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LTRPA
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
|
+$2.15M |
| 2 |
ICU Medical
ICUI
|
+$2.15M |
| 3 |
Skywest
SKYW
|
+$2.06M |
| 4 |
NAVG
Navigators Group Inc
NAVG
|
+$2.01M |
| 5 |
Insight Enterprises
NSIT
|
+$2.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.93% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Industrials | 12.56% |
| 4 | Technology | 10.41% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RELY
126
DELISTED
Real Industry, Inc.
RELY
| $992K | 0.27% |
162,585
-58,585
| -26% | -$340K |
|
127
Flexsteel Industries
FLXS
$306M
| $991K | 0.26% |
16,073
-20,615
| -56% | -$1.07M |
|
128
Celestica
CLS
$35.1B
| $989K | 0.26% |
+83,435
| New | +$978K |
|
129
Karyopharm Therapeutics
KPTI
$168M
| $987K | 0.26% |
+7,003
| New | +$947K |
|
130
AngioDynamics
ANGO
$562M
| $986K | 0.26% |
58,476
-57,108
| -49% | -$952K |
|
|
PRA
131
DELISTED
ProAssurance
PRA
| $986K | 0.26% |
+17,544
| New | +$972K |
|
132
Constellium
CSTM
$3.96B
| $976K | 0.26% |
165,402
-7,035
| -4% | -$43K |
|
|
OSG
133
DELISTED
Overseas Shipholding Group Inc.
OSG
| $976K | 0.26% |
254,797
+232,225
| +1,029% | +$1.69M |
|
134
WSFS Financial
WSFS
$4.1B
| $967K | 0.26% |
20,860
-1,702
| -8% | -$68.4K |
|
|
PRAH
135
DELISTED
PRA Health Sciences, Inc.
PRAH
| $966K | 0.26% |
17,527
+9,623
| +122% | +$528K |
|
|
ASCMA
136
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $962K | 0.26% |
+59,194
| New | +$1.17M |
|
|
TPC
137
Tutor Perini Cor
TPC
$4.57B
| $958K | 0.26% |
+34,228
| New | +$829K |
|
138
Liquidity Services
LQDT
$1.17B
| $955K | 0.26% |
97,961
-71,415
| -42% | -$682K |
|
139
Stagwell
STGW
$1.84B
| $952K | 0.25% |
+145,355
| New | +$1.07M |
|
|
ENDP
140
DELISTED
Endo International plc
ENDP
| $951K | 0.25% |
+57,745
| New | +$1.02M |
|
|
AFI
141
DELISTED
Armstrong Flooring, Inc.
AFI
| $951K | 0.25% |
47,752
+20,251
| +74% | +$373K |
|
142
Charles River Laboratories
CRL
$10.9B
| $949K | 0.25% |
12,461
-1,318
| -10% | -$100K |
|
|
PERY
143
DELISTED
Perry Ellis International Inc
PERY
| $949K | 0.25% |
38,096
-13,158
| -26% | -$295K |
|
|
LUMO
144
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $946K | 0.25% |
+10,227
| New | +$1.15M |
|
|
VWR
145
DELISTED
VWR Corporation
VWR
| $944K | 0.25% |
37,704
+5,295
| +16% | +$141K |
|
146
Terex
TEX
$7.98B
| $943K | 0.25% |
29,916
+9,355
| +45% | +$259K |
|
|
PKD
147
DELISTED
Parker Drilling Company
PKD
| $928K | 0.25% |
23,795
+17,234
| +263% | +$589K |
|
148
Cohu
COHU
$2.39B
| $909K | 0.24% |
65,404
-79,506
| -55% | -$968K |
|
149
Neurocrine Biosciences
NBIX
$17.7B
| $909K | 0.24% |
+23,493
| New | +$1.06M |
|
150
LivaNova
LIVN
$4.3B
| $900K | 0.24% |
+20,009
| New | +$983K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2016 Portfolio in Review
As of Q4 2016, TFS Capital held 1,045 positions worth $374M, down 10% from $418M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.
TFS Capital withdrew a net $66M in Q4 2016, closing 333 positions and reducing 228 holdings. Its most notable exit was Liberty TripAdvisor Holdings, Inc. Series A, an estimated $2.15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, TFS Capital opened a new position in MacroGenics worth $1.53M.
- TFS Capital's largest Q4 2016 buy was MacroGenics: 74,801 shares worth $1.53M.
- TFS Capital added most to Overseas Shipholding Group Inc. in Q4 2016, an estimated $1.69M increase.
- TFS Capital's biggest Q4 2016 reduction was ICU Medical, cutting an estimated $2.15M.
- TFS Capital fully exited Liberty TripAdvisor Holdings, Inc. Series A in Q4 2016, selling an estimated $2.15M.
- TFS Capital's ten largest holdings make up 5.1% of its $374M portfolio in Q4 2016.
- TFS Capital opened 320 new positions and closed 333 in Q4 2016.
- TFS Capital's portfolio value fell 10% quarter-over-quarter to $374M.
Based on TFS Capital's 13F filing for Q4 2016, filed 20 Jan 2017.